The new vaccine has a small piece of COVID-19 genetic material (messenger RNA) that 'instructs' cells in the human body 'to make the virus’s distinctive "spike" protein.' WASHINGTON, D.C., December 19, 2020 (LifeSiteNews) — The Unites States Food and Drug Administration has authorized the emergency use of a second COVID-19 vaccine. The FDA granted an emergency use authorization (EUA) to Moderna, a Massachusetts-based biotechnology company, yesterday. Like the Pfizer/BioNTech vaccine approved for use on December 10, the Moderna vaccine uses messenger RNA. The EUA comes as civil liberties advocates around the world raise concern over the possibility of “COVID passports”...